Search Results

You searched for : zepbound  

	Lilly’s Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease Mounjaro met the primary objective of non-inferiority vs. Trulicity with an 8% lower rate of MACE-3 events, while delivering greater reductions in A1C ... Aug 01
	Mounjaro (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine ... May 12
	Will Weight-Loss Drugs Solve the Obesity Crisis or Just Create More Problems? The WHO's endorsement of GLP-1 receptor agonists represents a significant development in the global fight against obesity.... May 08
	Cipla Eyes Eli Lilly Partnership to Tap Growing Demand for Obesity Drugs in India In response to the market demand, Indian drugmakers, including Cipla, are actively developing generic versions of these weight-loss drugs to secure a larger market ... May 13
	Biocon Ventures into Weight-Loss Drug Market with Semaglutide Development Biocon's foray into the weight-loss drug market aligns with its significant investment in generics research and development, with a notable focus on peptides ... Apr 20
	FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need ... Nov 17
6 Matching result(s) found!

Trending Now
	Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
	Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
	Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
	100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
	Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
	Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
	High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
	Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
	SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
	Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
	Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
	THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
	Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
	Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
	Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
	Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
	Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
	TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
	AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
	Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026